- A stringent scientific and regulatory input from Investigational New Drug (IND) to New Drug Application (NDA)
- We select an ‘entry’ indication to validate a mechanism of action before working on broader indications
- We have conducted clinical trials in Africa, Australia, Europe, North America, and are prepared to perform clinical truas on all continents
- We coordinate international product pharmacovigilance
Our people have broad clinical and medical expertise that encompasses the whole spectrum of drug discovery and development including proof of principle studies, Phase l and Phase ll studies, Phase lll pivotal trials, compassionate drug use and Phase lV programmes.
We have conducted over 80 clinical trials in 20 countries worldwide in therapeutic areas such as oncology, cardiovascular, endocrinology, immunology, neurology and infectious diseases.
